At the time of writing, DBV Technologies ADR [DBVT] stock is trading at $20.78, up 10.53%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DBVT shares have gain 22.16% over the last week, with a monthly amount glided 15.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DBV Technologies ADR [NASDAQ: DBVT] stock has seen the most recent analyst activity on December 15, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $42. Previously, Guggenheim started tracking the stock with Buy rating on December 03, 2025, and set its price target to $35. Societe Generale upgraded its rating to a Buy. Goldman downgraded its rating to a Sell. Goldman downgraded its rating to Neutral for this stock on May 10, 2022, and downed its price target to $1.50. In a note dated September 14, 2021, Societe Generale upgraded a Buy rating on this stock.
For the past year, the stock price of DBV Technologies ADR fluctuated between $3.80 and $26.18. Currently, Wall Street analysts expect the stock to reach $46.33 within the next 12 months. DBV Technologies ADR [NASDAQ: DBVT] shares were valued at $20.78 at the most recent close of the market. An investor can expect a potential return of 122.95% based on the average DBVT price forecast.
Analyzing the DBVT fundamentals
Gross Profit Margin for this corporation currently stands at -2.39% with Operating Profit Margin at -101.64%, Pretax Profit Margin comes in at -100.97%, and Net Profit Margin reading is -98.88%. To continue investigating profitability, this company’s Return on Assets is posted at -1.13, Equity is -2.95 and Total Capital is -2.11.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that DBV Technologies ADR [NASDAQ:DBVT] has a current ratio of 1.80. Further, the Quick Ratio stands at 1.80, while the Cash Ratio is 1.41.
Transactions by insiders
Recent insider trading involved EPIC Bpifrance, Member of 10% owner group, that happened on Dec 17 ’25 when 2.08 million shares were sold. Member of 10% owner group, EPIC Bpifrance completed a deal on Dec 18 ’25 to sell 1.29 million shares. Meanwhile, Chief Medical Officer Mohideen Pharis sold 6496.0 shares on Nov 20 ’25.
